Cargando…
Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing
CRISPR-Cas gene editing has revolutionized experimental molecular biology over the past decade and holds great promise for the treatment of human genetic diseases. Here we review the development of CRISPR-Cas9/Cas12/Cas13 nucleases, DNA base editors, prime editors, and RNA base editors, focusing on...
Autores principales: | Tao, Jianli, Bauer, Daniel E., Chiarle, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838544/ https://www.ncbi.nlm.nih.gov/pubmed/36639728 http://dx.doi.org/10.1038/s41467-023-35886-6 |
Ejemplares similares
-
Editing of mouse and human immunoglobulin genes by CRISPR-Cas9 system
por: Cheong, Taek-Chin, et al.
Publicado: (2016) -
Frequency and mechanisms of LINE-1 retrotransposon insertions at CRISPR/Cas9 sites
por: Tao, Jianli, et al.
Publicado: (2022) -
Recent advances in structural studies of the CRISPR-Cas-mediated genome editing tools
por: Zhu, Yuwei, et al.
Publicado: (2019) -
CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020) -
Computational Tools and Resources for CRISPR/Cas Genome Editing
por: Li, Chao, et al.
Publicado: (2023)